Neuhaus O - Search Results

1

Multiple sclerosis: Mitoxantrone promotes differential effects on immunocompetent cells in vitro.

Neuhaus O, Wiendl H, Kieseier BC, Archelos JJ, Hemmer B, Stüve O, Hartung HP. Neuhaus O, et al. J Neuroimmunol. 2005 Nov;168(1-2):128-37. doi: 10.1016/j.jneuroim.2005.01.024. J Neuroimmunol. 2005. PMID: 16171875

2

First case of adult onset neuronal intranuclear inclusion disease with both typical radiological signs and NOTCH2NLC repeat expansions in a Caucasian individual.

Podar IV, Gutmann DAP, Harmuth F, Haack TB, Ossowski S, Hengel H, Bornemann A, Schöls L, Neuhaus O. Podar IV, et al. Among authors: neuhaus o. Eur J Neurol. 2023 Sep;30(9):2854-2858. doi: 10.1111/ene.15905. Epub 2023 Jun 11. Eur J Neurol. 2023. PMID: 37271829

3

[The pathogenesis and diagnosis of Rasmussen encephalitis].

Wiendl H, Neuhaus O, Stefan H. Wiendl H, et al. Among authors: neuhaus o. Dtsch Med Wochenschr. 1999 Jul 30;124(30):901-4. doi: 10.1055/s-2007-1024450. Dtsch Med Wochenschr. 1999. PMID: 10464492 Review. German. No abstract available.

4

Multiple sclerosis: comparison of copolymer-1- reactive T cell lines from treated and untreated subjects reveals cytokine shift from T helper 1 to T helper 2 cells.

Neuhaus O, Farina C, Yassouridis A, Wiendl H, Then Bergh F, Dose T, Wekerle H, Hohlfeld R. Neuhaus O, et al. Proc Natl Acad Sci U S A. 2000 Jun 20;97(13):7452-7. doi: 10.1073/pnas.97.13.7452. Proc Natl Acad Sci U S A. 2000. PMID: 10861011 Free PMC article.

5

[Multiple sclerosis. Current review of failed and discontinued clinical trials of drug treatment].

Wiendl H, Neuhaus O, Kappos L, Hohlfeld R. Wiendl H, et al. Among authors: neuhaus o. Nervenarzt. 2000 Aug;71(8):597-610. doi: 10.1007/s001150050636. Nervenarzt. 2000. PMID: 10996910 Free PMC article. Review. German.

6

In search of a disease marker: the cytokine profile of primary progressive multiple sclerosis.

Neuhaus O, Hartung HP. Neuhaus O, et al. Mult Scler. 2001 Jun;7(3):143-4. doi: 10.1177/135245850100700301. Mult Scler. 2001. PMID: 11475435 Review. No abstract available.

7

[Treatment of multiple sclerosis with glatiramer acetate. Current aspects of mechanisms of action, pharmacokinetics, adverse effect profile and clinical studies].

Ziemssen T, Neuhaus O, Farina C, Hartung HP, Hohlfeld R. Ziemssen T, et al. Among authors: neuhaus o. Nervenarzt. 2002 Apr;73(4):321-31. doi: 10.1007/s00115-001-1257-0. Nervenarzt. 2002. PMID: 12040979 Review. German.

8

Statins as immunomodulators: comparison with interferon-beta 1b in MS.

Neuhaus O, Strasser-Fuchs S, Fazekas F, Kieseier BC, Niederwieser G, Hartung HP, Archelos JJ. Neuhaus O, et al. Neurology. 2002 Oct 8;59(7):990-7. doi: 10.1212/wnl.59.7.990. Neurology. 2002. PMID: 12370451

9

Immunomodulation in multiple sclerosis: from immunosuppression to neuroprotection.

Neuhaus O, Archelos JJ, Hartung HP. Neuhaus O, et al. Trends Pharmacol Sci. 2003 Mar;24(3):131-8. doi: 10.1016/S0165-6147(03)00028-2. Trends Pharmacol Sci. 2003. PMID: 12628358 Review.

10

Wiendl H, Neuhaus O, Mehling M, Wintterle S, Schreiner B, Mitsdoerffer M, Wienhold W, Weissert R, Wessels J, Hartung HP, Weller M, Tolosa E, Melms A. Wiendl H, et al. Among authors: neuhaus o. J Neuroimmunol. 2003 Jul;140(1-2):177-87. doi: 10.1016/s0165-5728(03)00172-3. J Neuroimmunol. 2003. PMID: 12864987

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

142 results

Search Page

Filters